The integration of therapy and diagnostics,
termed “theranostics”,
has recently gained widespread utility in the development of new and
improved therapeutics that effectively diagnose and treat diseases,
such as cancer. In this study, the covalent attachment of multiple
fluorescent labels (i.e., fluorescein isothiocyanate (FITC)) to a
wide range of siRNAs, including those adopting linear, V- and Y-shape
nanostructures, was successfully accomplished by solid-phase bioconjugation
for monitoring cell uptake, co-localization, and biological activity
in cell culture. The FITC-labeled higher-order V- and Y-shape siRNAs
maintained the requisite hybrid stabilities and A-type helical structures
for invoking RNAi activity. The FITC–siRNA hybrids with sense-strand
modifiers enabled efficient mRNA knockdown (∼50–90%),
which also translated to increased cell death (∼20–95%)
in a bone metastatic prostate cancer cell line, over a 72 h incubation
period. Significantly, the Y-shaped siRNA containing three FITC probes
enhanced fluorescent signaling relative to the siRNA constructs containing
single and double fluorophores while retaining potent knockdown and
cell death effects post-transfection. Taken together, this data highlights
the theranostic utility of the multilabeled FITC–siRNA constructs
for potential cancer gene therapy applications.